Pharma reform package ready for negotiations with EU Parliament
MLex Summary: Makers of innovative drugs will be able to prevent rivals from accessing the data used to develop them for a period of eight years, under a position on new...To view the full article, register now.
Already a subscriber? Click here to view full article